Nestor, Peter J. http://orcid.org/0000-0002-5860-5921
,
Altomare, Daniele
Festari, Cristina
Drzezga, Alexander
Rivolta, Jasmine
Walker, Zuzana
Bouwman, Femke
Orini, Stefania
Law, Ian
Agosta, Federica
Arbizu, Javier
Boccardi, Marina
Nobili, Flavio
Frisoni, Giovanni Battista
Article History
Received: 12 April 2018
Accepted: 18 April 2018
First Online: 7 May 2018
Compliance with ethical standards
:
: Peter Nestor received discounted radiotracer from Piramal for a research study.Flavio Nobili received personal fees and non-financial support from GE Healthcare, non-financial support from Eli Lilly and grants from Chiesi Farmaceutici.Cristina Festari declares that she has no conflict of interest.Daniele Altomare was the recipient of a grant allocated by the European Academy of Neurology (EAN) for data extraction and evidence assessment for the present project.Jasmine Gandolfo declares that she has no conflict of interest.Federica Agosta is Section Editor of NeuroImage: Clinical; has received speaker fees from Biogen Idec, Novartis, and Excellence in Medical Education; and receives or has received research support from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. She received personal fees from Elsevier Inc.Stefania Orini declares that she has no conflict of interest.Javier Arbizu received grants from Eli Lilly & Company, Piramal and GE Healthcare.Femke Bouwman declares that she has no conflict of interest.Alexander Drzezga received grants and non-financial support from Eli Lilly & Company, Siemens and GE Healthcare; he also received non-financial support from Piramal.Zuzana Walker received grants and tracers, personal fees for consultancy and speaker fees from GE Healthcare.Ian Law declares that he has no conflict of interest.Marina Boccardi has received funds from the European Association of Nuclear Medicine (EANM) to perform the evidence assessment and the global coordination of the present project. She has also received research grants from Piramal and served as a paid member of advisory boards for Eli Lilly.Giovanni B Frisoni is principal investigator of industry-sponsored trials funded by AbbVie, Acadia, Altoida, Amoneta, Araclon, Biogen, Janssen, Novartis and Piramal; has received funding for investigator-initiated trials from GE, Piramal, and Avid–Lilly; and has received speaker fees from a number of pharma and imaging companies.
: This is a review article that does not contain any original study with human participants performed by any of the authors. Ethical approval is shown in each of the quoted original papers.
: Not applicable; this is a review article. Informed consent statement is declared in each of the reviewed papers.